HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum insulin-like growth factors I and II are not affected by undernutrition in children with nonorganic failure to thrive.

Abstract
The aim of our study was to determine the serum levels of IGF-I, IGF-II, and their binding proteins IGFBP-1 and IGFBP-3 in young children 3 months to 2 years of age with nonorganic failure to thrive (NOFTT). 29 children with NOFTT and 32 normal controls were recruited and studied for auxologic and hormonal parameters. The NOFTT group had significantly higher serum concentrations of IGFBP-1 than the control group: 57.7+/-18 vs. 48+/-19 microg/l (p < 0.05). IGF-I and IGF-II serum levels were highly correlated to serum IGFBP-3 but there were no differences in the serum IGF-I, IGF-II and IGFBP-3 levels between the groups. We conclude that IGF-I, IGF-II, and IGFBP-3 are not useful for the evaluation of nutritional status in children, under the age of 2 years, with NOFTT.
AuthorsM Phillip, E Hershkovitz, H Rosenblum, I Savion, Y Segev, J Levy, D Frazer
JournalHormone research (Horm Res) Vol. 49 Issue 2 Pg. 76-9 ( 1998) ISSN: 0301-0163 [Print] Switzerland
PMID9485175 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Insulin-Like Growth Factor Binding Protein 1
  • Insulin-Like Growth Factor Binding Protein 2
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
Topics
  • Child, Preschool
  • Failure to Thrive (blood)
  • Female
  • Humans
  • Infant
  • Insulin-Like Growth Factor Binding Protein 1 (blood)
  • Insulin-Like Growth Factor Binding Protein 2 (blood)
  • Insulin-Like Growth Factor I (metabolism)
  • Insulin-Like Growth Factor II (metabolism)
  • Male
  • Nutrition Disorders (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: